Skip to main content
Clinical Trials/NCT06361628
NCT06361628
Not Yet Recruiting
N/A

Implementation and Evaluation of Tailored Interventions to Increase MMR and/or HPV Vaccine Uptake in Underserved Communities in Greece, The Netherlands, Poland and Slovakia

University Medical Center Groningen4 sites in 4 countries1,000 target enrollmentMay 1, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Vaccination
Sponsor
University Medical Center Groningen
Enrollment
1000
Locations
4
Primary Endpoint
Intention to vaccinate MMR and/or HPV by questionnaire
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of the study is to monitor and evaluate the implementation of interventions that aim to increase HPV & MMR vaccines among underserved communities across four European countries: Greece, Netherlands, Poland, and Slovakia. The interventions will target identified health systems barriers in an earlier phase of the project. The interventions that will be implemented employ trusted community members as health promotors whom will provide educational sessions on HPV and MMR vaccination to the target groups. In addition, the cost-effectiveness of vaccine uptake strategies for the target groups is being evaluated.

The main research question is: to what extent is the multicomponent tailored intervention effective to increase MMR/HPV intention and vaccine uptake in the target population in Greece, Netherlands, Poland and Slovakia?

Detailed Description

The general objective of the study is to improve access to vaccination by addressing relevant system level barriers to increase HPV and MMR (where applicable) vaccine intention and uptake among the target groups. The investigators expect that the intervention will address health system barriers to improve increase in access to information on vaccination and vaccination services. A prospective multicomponent intervention study will be performed between 1st of April 2024 and 31st of July 2025 that will be evaluated using a pre and post design as well as a participatory approach during the implementation. As part of the multicomponent intervention a preparatory phase is taken place before this period of time. The multicomponent intervention consists of training of health promotors and healthcare professionals, and of educational sessions to community members and navigation. The educational sessions will be offered at suitable and accessible locations for the target population. The five communities targeted in are the following: 1. The migrant community in Greece (HPV and MMR) 2. Turkish and Moroccan women in the Netherlands (HPV) 3. The Ukrainian community in Poland (HPV and MMR) 4. The Roma community in Slovakia (HPV)

Registry
clinicaltrials.gov
Start Date
May 1, 2024
End Date
June 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • parents of children eligible for MMR and/or HPV vaccination according to country guidelines on those specific vaccines

Exclusion Criteria

  • respondents not willing or able to fill out questionnaires

Outcomes

Primary Outcomes

Intention to vaccinate MMR and/or HPV by questionnaire

Time Frame: Pre and immediately following the intervention and 6 month post intervention

Intention for vaccination against MMR and/or HPV among the underserved communities

Secondary Outcomes

  • Uptake of MMR and/or HPV vaccinations by questionnaire(Pre and 6 month post intervention evaluation is necessary)
  • Communication skills of health care professionals using a questionnaire(Pre intervention and directly post intervention)
  • Satisfaction of the stakeholders as measured by a questionnaire(Directly post intervention)
  • Knowledge concerning MMR and/or HPV vaccinations in the target group using a questionnaire(Pre and immediately following the intervention and 6 month post intervention evaluation)

Study Sites (4)

Loading locations...

Similar Trials